Results 281 to 290 of about 1,058,875 (320)

Efficacy and safety of switching to iGlarLixi from premixed insulins in people with type 2 diabetes: The Soli-SWITCH study. [PDF]

open access: yesDiabetes Obes Metab
Haluzík M   +6 more
europepmc   +1 more source

Insulins for Insulin Resistance

Annals of Internal Medicine, 1981
Excerpt To the editor: Dr. Galloway (1) notes in his comment on our article "U-500 Insulin in the Treatment of Antibody-Mediated Insulin Resistance" (2) that we did not compare equivalent doses of ...
David M. Nathan, Lloyd Axelrod
openaire   +3 more sources

Insulin autoantibodies and insulin assay

Diabetes, 1988
Insulin antibodies are known to interfere with the radioimmunoassay of insulin. We tested intravenous glucose tolerance on 25 insulin autoantibody-positive (IAA+) patients and 25 IAA− controls, who were matched for sex, age, and body mass index, to establish if IAA could also interfere with insulin assay. Insulin content was measured in untreated serum,
Peter J. Wood   +4 more
openaire   +2 more sources

Insulin, insulin receptors, and cancer

Journal of Endocrinological Investigation, 2016
Insulin is a major regulator of cell metabolism but, in addition, is also a growth factor. Insulin effects in target cells are mediated by the insulin receptor (IR), a transmembrane protein with enzymatic (tyrosine kinase) activity. The insulin receptor, however, is represented by a heterogeneous family of proteins, including two different IR isoforms ...
Vigneri R   +2 more
openaire   +3 more sources

Insulin Resistance and Insulin Sensitizers

Hormone Research in Paediatrics, 2001
Insulin resistance is a key factor in the pathogenesis of type 2 diabetes mellitus and a co-factor in the development of dyslipidaemia, hypertension and atherosclerosis. The causes of insulin resistance include factors such as obesity and physical inactivity, and there may also be genetic factors.
Michael Stumvoll, Hans U. Häring
openaire   +3 more sources

Insulin in blood and insulin antibodies

The American Journal of Medicine, 1966
T HIS presentation is concerned with the state of insulin in plasma rather than the physiologic regulation of insulin secretion. Our own studies on the concentrations of immunoassayable insulin in blood in hyperglycemic and hypoglycemic states have recently been summarized elsewhere [ 7-31.
Rosalyn S. Yalow, Solomon A. Berson
openaire   +3 more sources

SERUM-INSULIN OR PLASMA-INSULIN ?

The Lancet, 1970
Abstract The concentration of insulin was measured by double-antibody immunoassay simultaneously in the plasma and serum of thirty-eight fasting and non-fasting individuals. The concentration found in heparin-plasma was consistently higher than that found in serum, and experiments suggest that the high plasma-level is an effect of heparin.
openaire   +5 more sources

Home - About - Disclaimer - Privacy